Format
Scientific article
Publication Date
Published by / Citation
JAMA Internal Medicine: 2018, 178(6), p. 764-773.
Keywords
illegal drugs
buprenorphine
pharmacotherapy
agonist
treatment
non-residential
heroin
long-acting
formulation
safety
side effects
retention
completion
craving
suboxone
injectable
opioid maintenance
Opioid Substitution Treatment

Effectiveness Bank Analysis: UPDATED Long-Acting Buprenorphine an Advance on Daily Doses

*Updated with UK licensing information and advice released in February 2019 by the National Institute for Health and Care Excellence*

What could prove a technical advance in the medication-based treatment of dependence on heroin and allied drugs was rigorously tested and partially vindicated among hundreds of patients at over 30 US clinics.